{"Title": "Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: A multi-institution correlative biomarker study", "Year": 2017, "Source": "Ann. Oncol.", "Volume": "28", "Issue": 7, "Art.No": null, "PageStart": 1, "PageEnd": 9, "CitedBy": 118, "DOI": "10.1093/annonc/mdx155", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85019315640&origin=inward", "Abstract": "\u00a9 The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology.Background: There is an urgent need to identify biomarkers to guide personalized therapy in castration-resistant prostate cancer (CRPC). We aimed to clinically qualify androgen receptor (AR) gene status measurement in plasma DNA using multiplex droplet digital PCR (ddPCR) in pre- and post-chemotherapy CRPC. Methods: We optimized ddPCR assays for AR copy number and mutations and retrospectively analyzed plasma DNA from patients recruited to one of the three biomarker protocols with prospectively collected clinical data. We evaluated associations between plasma AR and overall survival (OS) and progression-free survival (PFS) in 73 chemotherapy-na\u00efve and 98 postdocetaxel CRPC patients treated with enzalutamide or abiraterone (Primary cohort) and 94 chemotherapy-na\u00efve patients treated with enzalutamide (Secondary cohort; PREMIERE trial). Results: In the primary cohort, AR gain was observed in 10 (14%) chemotherapy-na\u00efve and 33 (34%) post-docetaxel patients and associated with worse OS [hazard ratio (HR), 3.98; 95% CI 1.74-9.10; P < 0.001 and HR 3.81; 95% CI 2.28-6.37; P < 0.001, respectively], PFS (HR 2.18; 95% CI 1.08-4.39; P=0.03, and HR 1.95; 95% CI 1.23-3.11; P=0.01, respectively) and rate of PSA decline \u226550% [odds ratio (OR), 4.7; 95% CI 1.17-19.17; P=0.035 and OR, 5.0; 95% CI 1.70-14.91; P=0.003, respectively]. ARmutations [2105T > A (p. L702H) and 2632A > G (p. T878A)] were observed in eight (11%) post-docetaxel but no chemotherapy-na\u00efve abiraterone-treated patients and were also associated with worse OS (HR 3.26; 95% CI 1.47-not reached; P=0.004). There was no interaction between AR and docetaxel status (P=0.83 for OS, P=0.99 for PFS). In the PREMIERE trial, 11 patients (12%) with AR gain had worse PSA-PFS (sPFS) (HR 4.33; 95% CI 1.94-9.68; P < 0.001), radiographic-PFS (rPFS) (HR 8.06; 95% CI 3.26-19.93; P < 0.001) and OS (HR 11.08; 95% CI 2.16-56.95; P=0.004). Plasma AR was an independent predictor of outcome on multivariable analyses in both cohorts. Conclusion: Plasma AR status assessment using ddPCR identifies CRPC with worse outcome to enzalutamide or abiraterone. Prospective evaluation of treatment decisions based on plasma AR is now required.", "AuthorKeywords": ["Abiraterone", "Androgen receptor", "Biomarker", "Castration-resistant prostate cancer", "Enzalutamide", "Plasma DNA"], "IndexKeywords": ["Adult", "Aged", "Aged, 80 and over", "Androstenes", "Antineoplastic Agents, Hormonal", "Biomarkers, Tumor", "Circulating Tumor DNA", "Disease Progression", "Disease-Free Survival", "DNA Mutational Analysis", "Europe", "Humans", "Kaplan-Meier Estimate", "Male", "Middle Aged", "Multiplex Polymerase Chain Reaction", "Multivariate Analysis", "Mutation", "Odds Ratio", "Patient Selection", "Phenylthiohydantoin", "Precision Medicine", "Predictive Value of Tests", "Proportional Hazards Models", "Prospective Studies", "Prostatic Neoplasms, Castration-Resistant", "Receptors, Androgen", "Risk Factors", "Time Factors", "Treatment Outcome"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85019315640", "SubjectAreas": [["Hematology", "MEDI", "2720"], ["Oncology", "MEDI", "2730"]], "AuthorData": {"25026993100": {"Name": "Conteduca V.", "AuthorID": "25026993100", "AffiliationID": "60083104", "AffiliationName": "Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS"}, "7801390878": {"Name": "Wetterskog D.", "AuthorID": "7801390878", "AffiliationID": "60010337", "AffiliationName": "Centre for Evolution and Cancer, The Institute of Cancer Research"}, "56667360900": {"Name": "Jayaram A.", "AuthorID": "56667360900", "AffiliationID": "60017166", "AffiliationName": "Academic Urology Unit, The Royal Marsden NHS Foundation Trust"}, "55617586500": {"Name": "Gasi Tandefelt D.", "AuthorID": "55617586500", "AffiliationID": "60010337", "AffiliationName": "Centre for Evolution and Cancer, The Institute of Cancer Research"}, "55204494900": {"Name": "Wingate A.", "AuthorID": "55204494900", "AffiliationID": "60010337", "AffiliationName": "Centre for Evolution and Cancer, The Institute of Cancer Research"}, "9740870900": {"Name": "Attard G.", "AuthorID": "9740870900", "AffiliationID": "60017166", "AffiliationName": "Academic Urology Unit, The Royal Marsden NHS Foundation Trust"}, "55620670700": {"Name": "Salvi S.", "AuthorID": "55620670700", "AffiliationID": "60083104", "AffiliationName": "Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS"}, "26658575200": {"Name": "Lolli C.", "AuthorID": "26658575200", "AffiliationID": "60083104", "AffiliationName": "Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS"}, "57192309971": {"Name": "Casadio V.", "AuthorID": "57192309971", "AffiliationID": "60083104", "AffiliationName": "Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS"}, "56271512300": {"Name": "Gurioli G.", "AuthorID": "56271512300", "AffiliationID": "60083104", "AffiliationName": "Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS"}, "7005467871": {"Name": "Amadori D.", "AuthorID": "7005467871", "AffiliationID": "60083104", "AffiliationName": "Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS"}, "57201019208": {"Name": "De Giorgi U.", "AuthorID": "57201019208", "AffiliationID": "60083104", "AffiliationName": "Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS"}, "36195655500": {"Name": "Sharabiani M.T.A.", "AuthorID": "36195655500", "AffiliationID": "60017166", "AffiliationName": "Research Data Management and Statistics Unit, The Royal Marsden NHS Foundation Trust"}, "16554800300": {"Name": "Grande E.", "AuthorID": "16554800300", "AffiliationID": "60021609", "AffiliationName": "Department of Medical Oncology, Hospital Ram\u00f3n y Cajal"}, "55179053100": {"Name": "Fernandez-Perez M.P.", "AuthorID": "55179053100", "AffiliationID": "60027471, 60000130", "AffiliationName": "Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, IMIB-Universidad de Murcia"}, "24449144100": {"Name": "Gonzalez-Billalabeitia E.", "AuthorID": "24449144100", "AffiliationID": "60109394", "AffiliationName": "Department of Medical Oncology, Universidad Cat\u00f3lica San Antonio de Murcia-UCAM"}, "7004428943": {"Name": "Dearnaley D.", "AuthorID": "7004428943", "AffiliationID": "60010337", "AffiliationName": "Division of Radiotherapy and Imaging, The Institute of Cancer Research"}, "55901642500": {"Name": "Castellano D.", "AuthorID": "55901642500", "AffiliationID": "60004024", "AffiliationName": "Department of Medical Oncology, Hospital Universitario 12 de Octubre"}, "57202380763": {"Name": "Romanel A.", "AuthorID": "57202380763", "AffiliationID": "60015986", "AffiliationName": "Centre for Integrative Biology, University of Trento"}, "35276956300": {"Name": "Demichelis F.", "AuthorID": "35276956300", "AffiliationID": "60007997", "AffiliationName": "Institute for Precision Medicine, Weill Cornell Medicine"}, "7005457752": {"Name": "Font A.", "AuthorID": "7005457752", "AffiliationID": "60028462", "AffiliationName": "Oncology Unit, Institut Catal\u00e0 d'Oncologia-Hospital Germans Trias i Pujol"}, "6505999664": {"Name": "Vazquez-Estevez S.", "AuthorID": "6505999664", "AffiliationID": "109957754", "AffiliationName": "Department of Medical Oncology, H. Universitario Lucus Augusti"}, "41161360000": {"Name": "Gonz\u00e1lez del Alba A.", "AuthorID": "41161360000", "AffiliationID": "60000608", "AffiliationName": "Department of Medical Oncology, H.U. Son Espases Mallorca"}, "7005083027": {"Name": "Mellado B.", "AuthorID": "7005083027", "AffiliationID": "60030315, 60010814", "AffiliationName": "Department of Medical Oncology, IDIBAPS Hospital Clinic"}, "24586764800": {"Name": "Fernandez-Calvo O.", "AuthorID": "24586764800", "AffiliationID": "113210053", "AffiliationName": "Department of Medical Oncology, Hospital de Orense"}, "6506376076": {"Name": "M\u00e9ndez-Vidal M.J.", "AuthorID": "6506376076", "AffiliationID": "60031142", "AffiliationName": "Department of Medical Oncology, Hospital Universitario Reina Sof\u00eda"}, "7003954884": {"Name": "Climent M.A.", "AuthorID": "7003954884", "AffiliationID": "60005788", "AffiliationName": "Department of Medical Oncology, Instituto Valenciano de Oncolog\u00eda Valencia"}, "7005607034": {"Name": "Duran I.", "AuthorID": "7005607034", "AffiliationID": "60033267, 60033284, 60006754, 60103764", "AffiliationName": "Department of Medical Oncology, Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Roc\u00edo/CSIC/Universidad de Sevilla"}, "7007144404": {"Name": "Gallardo E.", "AuthorID": "7007144404", "AffiliationID": "113064639", "AffiliationName": "Department of Medical Oncology, H.U. Parc Taul\u00ed"}, "54976685900": {"Name": "Rodriguez A.", "AuthorID": "54976685900", "AffiliationID": "60009473", "AffiliationName": "Department of Medical Oncology, Hospital de Le\u00f3n"}, "6602531234": {"Name": "Santander C.", "AuthorID": "6602531234", "AffiliationID": "60022336", "AffiliationName": "Department of Medical Oncology, Hospital Universitario Miguel Servet"}, "54279403400": {"Name": "S\u00e1ez M.I.", "AuthorID": "54279403400", "AffiliationID": "60000252, 60013124", "AffiliationName": "Department of Medical Oncology, Hospital Regional y Hospital Virgen de la Victoria"}, "57196697184": {"Name": "Puente J.", "AuthorID": "57196697184", "AffiliationID": "60032461", "AffiliationName": "Department of Medical Oncology, Hospital Cl\u00ednico San Carlos"}, "12785612100": {"Name": "Alonso T.", "AuthorID": "12785612100", "AffiliationID": "60021609", "AffiliationName": "Servicio de Oncologiva M\u00e9dica, Hospital Ram\u00f3n y Cajal"}, "7005192029": {"Name": "Tudela J.", "AuthorID": "7005192029", "AffiliationID": "60027471", "AffiliationName": "Servicio de Anatom\u00eda Patol\u00f3gica, Hospital Morales Meseguer"}, "7404025603": {"Name": "Martinez A.", "AuthorID": "7404025603", "AffiliationID": "105741181", "AffiliationName": "Biobanco de la Regi\u00f3n de Murcia, IMIB Nodo 3"}, "null": {"Name": null, "AuthorID": null, "AffiliationID": null, "AffiliationName": null}}}